Yahoo Web Search

Search results

    • Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 54 minutes ago

      We believe the approval of ZYNQUISTA would help address significant unmet needs in a population with no real treatment options beyond insulin to manage their blood sugar.

    • Q1 2024 Vir Biotechnology Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 hours ago

      While this is our stated goal KOLs. We hosted an advisory...that for an interferon-free regimen. We expect to report 48 week end of treatment data for the March 14th trial at a major

    • Senior TLC set to open in Shelby

      Senior TLC set to open in Shelby

      Gannett via AOL· 4 days ago

      The program is for people ages 55 and up and provides a full range of services, including social, recreation, physical, medical and more, that is...

    • Q1 2024 Illumina Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 hour ago

      One key area of focus is harnessing whole genome opportunities in minimal residual disease. Other customers are starting to sequence deeper and are adding multiomics layers to their projects ...

    • Q1 2024 SpringWorks Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 10 hours ago

      A second key priority for us is the significant opportunity we see for Merimepodib, our MET inhibitor to help a large number of patients with neurofibromatosis type one associated ...